Eye tracking could unlock new biomarker for angelman syndrome
NCT ID NCT06737718
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will use eye tracking to measure how children with Angelman syndrome look at social and non-social images. Researchers hope to identify abnormalities in social perception that could serve as a biomarker for future treatment trials. The study includes 40 children with Angelman syndrome and 20 healthy controls, all aged 3 to 17.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, eye tracking could become a reliable biomarker to measure social improvements in future Angelman syndrome clinical trials.
- What could go wrong
- This is an early observational study with only 60 participants, so results may not apply to all children with Angelman syndrome. Eye tracking may not detect meaningful differences.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGELMAN SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Necker-Enfants Malades
RECRUITINGParis, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can early parent coaching help infants with rare genetic disorders thrive?
- Newborn screening study aims to catch rare diseases at birth
- New hope for angelman syndrome: drug trial targets brain function
- New registry aims to shed light on angelman syndrome
- New study tracks angelman syndrome progression in kids and adults
- 2000-Patient study aims to uncover hidden metabolic risks in rare genetic disorders